Tech Company Financing Transactions
Nuron Biotech Funding Round
On 12/21/2012, Nuron Biotech raised $80 million in funding from HealthCare Royalty Partners.
Transaction Overview
Company Name
Announced On
12/21/2012
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Undisclosed
Investors
HealthCare Royalty Partners (Gregory Brown)
Proceeds Purpose
Proceeds will support the commercialization and expansion of Meningitec, recently acquired from Pfizer Inc., an established commercial vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C. In addition, proceeds will be used to support the clinical development of the company's novel biologics and vaccines for infectious and neurodegenerative diseases, including HibTITER and NU100, a multiple sclerosis treatment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 East Uwchlan Ave. 302
Exton, PA 19341
USA
Exton, PA 19341
USA
Phone
Website
Email Address
Overview
Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. Our team of industry veterans is advancing products to meet unmet medical needs in the areas of multiple sclerosis, Alzheimer's, Hepatitis B and Hepatitis C for patients across the globe.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Warren Cooper
Chief Financial Officer
Wendy DiCicco
Chief Medical Officer
Robert Walker
VP - General Counsel
Andrew Romberger
VP - Manufacturing
Tharuvai Ramesh
VP - R & D
Daniel Cushing
Browse more venture capital transactions:
Prev: 12/21/2012: Elcelyx Therapeutics venture capital transaction
Next: 12/21/2012: CartaSite venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs